Abstract
A substantial increase in the incidence of oesophageal adenocarcinoma has been observed in Western countries during the past 30 years, which may be related to the parallel rise of the obesity prevalence. On the other hand, incidence rates of oesophageal squamous cell carcinomas, the other major histological type of oesophageal cancer, have remained relatively stable. Epidemiological research of the past decades has identified obesity as risk factor for oesophageal adenocarcinoma. Studies investigating general obesity as assessed by body mass index (BMI) provide evidence for a strong positive association with oesophageal adenocarcinoma. Studies investigating abdominal obesity in relation to oesophageal adenocarcinoma observed also positive associations, which may be independent of general obesity. Some studies indicate that early life obesity is also associated with higher risk of oesophageal adenocarcinoma, but it is as to date unclear whether these associations are independent of adult obesity. Part of the positive association between obesity and oesophageal adenocarcinoma may be explained through obesity-related mechanical promotion of gastroesophageal reflux disease, which is one of the main risk factors for oesophageal adenocarcinoma. Other lines of evidence point to an independent role of metabolic pathways modulating cell proliferation, apoptosis and cell growth such as pro-inflammatory cytokines, adipokines and insulin resistance, the role of which in oesophageal carcinogenesis is, however, as to date insufficiently understood. Studies investigating obesity in relation to squamous cell carcinoma observed inverse relationships, but the underlying mechanisms remain unclear.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Fitzmaurice C, Dicker D, Pain A, Hamavid H, Moradi-Lakeh M, MacIntyre MF, Allen C, Hansen G, Woodbrook R, Wolfe C, Hamadeh RR, Moore A, Werdecker A, Gessner BD, Te Ao B, McMahon B, Karimkhani C, Yu C, Cooke GS, Schwebel DC, Carpenter DO, Pereira DM, Nash D, Kazi DS, De Leo D, Plass D, Ukwaja KN, Thurston GD, Yun Jin K, Simard EP, Mills E, Park EK, Catala-Lopez F, deVeber G, Gotay C, Khan G, Hosgood HD 3rd, Santos IS, Leasher JL, Singh J, Leigh J, Jonas JB, Sanabria J, Beardsley J, Jacobsen KH, Takahashi K, Franklin RC, Ronfani L, Montico M, Naldi L, Tonelli M, Geleijnse J, Petzold M, Shrime MG, Younis M, Yonemoto N, Breitborde N, Yip P, Pourmalek F, Lotufo PA, Esteghamati A, Hankey GJ, Ali R, Lunevicius R, Malekzadeh R, Dellavalle R, Weintraub R, Lucas R, Hay R, Rojas-Rueda D, Westerman R, Sepanlou SG, Nolte S, Patten S, Weichenthal S, Abera SF, Fereshtehnejad SM, Shiue I, Driscoll T, Vasankari T, Alsharif U, Rahimi-Movaghar V, Vlassov VV, Marcenes WS, Mekonnen W, Melaku YA, Yano Y, Artaman A, Campos I, MacLachlan J, Mueller U, Kim D, Trillini M, Eshrati B, Williams HC, Shibuya K, Dandona R, Murthy K, Cowie B, Amare AT, Antonio CA, Castaneda-Orjuela C, van Gool CH, Violante F, Oh IH, Deribe K, Soreide K, Knibbs L, Kereselidze M, Green M, Cardenas R, Roy N, Tillmann T, Li Y, Krueger H, Monasta L, Dey S, Sheikhbahaei S, Hafezi-Nejad N, Kumar GA, Sreeramareddy CT, Dandona L, Wang H, Vollset SE, Mokdad A, Salomon JA, Lozano R, Vos T, Forouzanfar M, Lopez A, Murray C, Naghavi M (2015) The global burden of cancer 2013. JAMA Oncol 1(4):505–527. doi:10.1001/jamaoncol.2015.0735
Pennathur A, Gibson MK, Jobe BA, Luketich JD (2013) Oesophageal carcinoma. Lancet 381(9864):400–412. doi:10.1016/S0140-6736(12)60643-6
Domper Arnal MJ, Ferrandez Arenas A, Lanas Arbeloa A (2015) Esophageal cancer: risk factors, screening and endoscopic treatment in Western and Eastern countries. World J Gastroenterol (WJG) 21(26):7933–7943. doi:10.3748/wjg.v21.i26.7933
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136(5):E359–E386. doi:10.1002/ijc.29210
Vizcaino AP, Moreno V, Lambert R, Parkin DM (2002) Time trends incidence of both major histologic types of esophageal carcinomas in selected countries, 1973–1995. Int J Cancer 99(6):860–868. doi:10.1002/ijc.10427
Ryan AM, Duong M, Healy L, Ryan SA, Parekh N, Reynolds JV, Power DG (2011) Obesity, metabolic syndrome and esophageal adenocarcinoma: epidemiology, etiology and new targets. Cancer Epidemiol 35(4):309–319. doi:10.1016/j.canep.2011.03.001
Pandeya N, Olsen CM, Whiteman DC (2013) Sex differences in the proportion of esophageal squamous cell carcinoma cases attributable to tobacco smoking and alcohol consumption. Cancer Epidemiol 37(5):579–584. doi:10.1016/j.canep.2013.05.011
Adami HO, Hunter D, Trichopoulos D (2008) Textbook of cancer epidemiology. Oxford University Press, Oxford
Hoyo C, Cook MB, Kamangar F, Freedman ND, Whiteman DC, Bernstein L, Brown LM, Risch HA, Ye W, Sharp L, Wu AH, Ward MH, Casson AG, Murray LJ, Corley DA, Nyren O, Pandeya N, Vaughan TL, Chow WH, Gammon MD (2012) Body mass index in relation to oesophageal and oesophagogastric junction adenocarcinomas: a pooled analysis from the International BEACON Consortium. Int J Epidemiol 41(6):1706–1718. doi:10.1093/ije/dys176
Kubo A, Corley DA (2006) Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis. Cancer Epidemiol Biomark Prev 15(5):872–878. doi:10.1158/1055-9965.EPI-05-0860
Turati F, Tramacere I, La Vecchia C, Negri E (2013) A meta-analysis of body mass index and esophageal and gastric cardia adenocarcinoma. Ann Oncol (Official Journal of the European Society for Medical Oncology/ESMO) 24(3):609–617. doi:10.1093/annonc/mds244
Lindkvist B, Johansen D, Stocks T, Concin H, Bjorge T, Almquist M, Haggstrom C, Engeland A, Hallmans G, Nagel G, Jonsson H, Selmer R, Ulmer H, Tretli S, Stattin P, Manjer J (2014) Metabolic risk factors for esophageal squamous cell carcinoma and adenocarcinoma: a prospective study of 580,000 subjects within the Me-Can project. BMC Cancer 14:103. doi:10.1186/1471-2407-14-103
Lagergren J (2011) Influence of obesity on the risk of esophageal disorders. Nat Rev Gastroenterol Hepatol 8(6):340–347. doi:10.1038/nrgastro.2011.73
Singh S, Sharma AN, Murad MH, Buttar NS, El-Serag HB, Katzka DA, Iyer PG (2013) Central adiposity is associated with increased risk of esophageal inflammation, metaplasia, and adenocarcinoma: a systematic review and meta-analysis. Clin Gastroenterol Hepatol (The Official Clinical Practice Journal of the American Gastroenterological Association) 11(11):1399–1412 e1397. doi:10.1016/j.cgh.2013.05.009
Steffen A, Huerta JM, Weiderpass E, Bueno-de-Mesquita HB, May AM, Siersema PD, Kaaks R, Neamat-Allah J, Pala V, Panico S, Saieva C, Tumino R, Naccarati A, Dorronsoro M, Sanchez-Cantalejo E, Ardanaz E, Quiros JR, Ohlsson B, Johansson M, Wallner B, Overvad K, Halkjaer J, Tjonneland A, Fagherazzi G, Racine A, Clavel-Chapelon F, Key TJ, Khaw KT, Wareham N, Lagiou P, Bamia C, Trichopoulou A, Ferrari P, Freisling H, Lu Y, Riboli E, Cross AJ, Gonzalez CA, Boeing H (2015) General and abdominal obesity and risk of esophageal and gastric adenocarcinoma in the European prospective investigation into cancer and nutrition. Int J Cancer 137(3):646–657. doi:10.1002/ijc.29432
O’Doherty MG, Freedman ND, Hollenbeck AR, Schatzkin A, Abnet CC (2012) A prospective cohort study of obesity and risk of oesophageal and gastric adenocarcinoma in the NIH-AARP diet and health study. Gut 61(9):1261–1268. doi:10.1136/gutjnl-2011-300551
Steffen A, Schulze MB, Pischon T, Dietrich T, Molina E, Chirlaque MD, Barricarte A, Amiano P, Quiros JR, Tumino R, Mattiello A, Palli D, Vineis P, Agnoli C, Misirli G, Boffetta P, Kaaks R, Rohrmann S, Bueno-de-Mesquita HB, Peeters PH, May AM, Spencer EA, Allen NE, Bingham S, Tjonneland A, Halkjaer J, Overvad K, Stegger J, Manjer J, Lindkvist B, Hallmanns G, Stenling R, Lund E, Riboli E, Gonzalez CA, Boeing H (2009) Anthropometry and esophageal cancer risk in the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomark Prev 18(7):2079–2089. doi:10.1158/1055-9965.EPI-09-0265
Zhang X, Wu K, Giovannucci EL, Ma J, Colditz GA, Fuchs CS, Willett WC, Stampfer MJ, Nimptsch K, Ogino S, Wei EK (2015) Early life body fatness and risk of colorectal cancer in u.s. Women and men-results from two large cohort studies. Cancer Epidemiol Biomark Prev 24(4):690–697. doi:10.1158/1055-9965.EPI-14-0909-T
Nimptsch K, Giovannucci E, Willett WC, Fuchs CS, Wei EK, Wu K (2011) Body fatness during childhood and adolescence, adult height, and risk of colorectal adenoma in women. Cancer Prev Res 4(10):1710–1718. doi:10.1158/1940-6207.CAPR-11-0272
Koebnick C, Getahun D, Smith N, Porter AH, Der-Sarkissian JK, Jacobsen SJ (2011) Extreme childhood obesity is associated with increased risk for gastroesophageal reflux disease in a large population-based study. Int J Pediatr Obes: IJPO (An Official Journal of the International Association for the Study of Obesity) 6(2–2):e257–e263. doi:10.3109/17477166.2010.491118
Levi Z, Kark JD, Shamiss A, Derazne E, Tzur D, Keinan-Boker L, Liphshitz I, Niv Y, Furman M, Afek A (2013) Body mass index and socioeconomic status measured in adolescence, country of origin, and the incidence of gastroesophageal adenocarcinoma in a cohort of 1 million men. Cancer 119(23):4086–4093. doi:10.1002/cncr.28241
Cook MB, Freedman ND, Gamborg M, Sorensen TI, Baker JL (2015) Childhood body mass index in relation to future risk of oesophageal adenocarcinoma. Br J Cancer 112(3):601–607. doi:10.1038/bjc.2014.646
Aarestrup J, Bjerregaard LG, Gamborg M, Angquist L, Tjonneland A, Overvad K, Linneberg A, Osler M, Mortensen EL, Gyntelberg F, Lund R, Tia S, Baker JL (2016) Tracking of body mass index from 7 to 69 years of age. Int J Obes (2005). doi:10.1038/ijo.2016.88
Smith M, Zhou M, Whitlock G, Yang G, Offer A, Hui G, Peto R, Huang Z, Chen Z (2008) Esophageal cancer and body mass index: results from a prospective study of 220,000 men in China and a meta-analysis of published studies. Int J Cancer 122(7):1604–1610. doi:10.1002/ijc.23198
Enzinger PC, Mayer RJ (2003) Esophageal cancer. N Engl J Med 349(23):2241–2252. doi:10.1056/NEJMra035010
Fahey PP, Mallitt KA, Astell-Burt T, Stone G, Whiteman DC (2015) Impact of pre-diagnosis behavior on risk of death from esophageal cancer: a systematic review and meta-analysis. Cancer Causes Control 26(10):1365–1373. doi:10.1007/s10552-015-0635-z
Trivers KF, De Roos AJ, Gammon MD, Vaughan TL, Risch HA, Olshan AF, Schoenberg JB, Mayne ST, Dubrow R, Stanford JL, Abrahamson P, Rotterdam H, West AB, Fraumeni JF, Chow WH (2005) Demographic and lifestyle predictors of survival in patients with esophageal or gastric cancers. Clin Gastroenterol Hepatol (The Official Clinical Practice Journal of the American Gastroenterological Association) 3(3):225–230
Thrift AP, Nagle CM, Fahey PP, Smithers BM, Watson DI, Whiteman DC (2012) Predictors of survival among patients diagnosed with adenocarcinoma of the esophagus and gastroesophageal junction. Cancer Causes Control 23(4):555–564. doi:10.1007/s10552-012-9913-1
Sundelof M, Lagergren J, Ye W (2008) Patient demographics and lifestyle factors influencing long-term survival of oesophageal cancer and gastric cardia cancer in a nationwide study in Sweden. Eur J Cancer 44(11):1566–1571. doi:10.1016/j.ejca.2008.04.002
Chan DS, Vieira AR, Aune D, Bandera EV, Greenwood DC, McTiernan A, Navarro Rosenblatt D, Thune I, Vieira R, Norat T (2014) Body mass index and survival in women with breast cancer-systematic literature review and meta-analysis of 82 follow-up studies. Ann Oncol (Official Journal of the European Society for Medical Oncology/ESMO) 25(10):1901–1914. doi:10.1093/annonc/mdu042
Lee J, Meyerhardt JA, Giovannucci E, Jeon JY (2015) Association between body mass index and prognosis of colorectal cancer: a meta-analysis of prospective cohort studies. PLoS ONE 10(3):e0120706. doi:10.1371/journal.pone.0120706
Renehan AG, Sperrin M (2016) The obesity paradox and mortality after colorectal cancer: a causal conundrum. JAMA Oncol. doi:10.1001/jamaoncol.2016.0868
Lagergren J, Bergstrom R, Nyren O (1999) Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med 130(11):883–890
Chow WH, Blot WJ, Vaughan TL, Risch HA, Gammon MD, Stanford JL, Dubrow R, Schoenberg JB, Mayne ST, Farrow DC, Ahsan H, West AB, Rotterdam H, Niwa S, Fraumeni JF Jr (1998) Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst 90(2):150–155
Thrift AP, Shaheen NJ, Gammon MD, Bernstein L, Reid BJ, Onstad L, Risch HA, Liu G, Bird NC, Wu AH, Corley DA, Romero Y, Chanock SJ, Chow WH, Casson AG, Levine DM, Zhang R, Ek WE, MacGregor S, Ye W, Hardie LJ, Vaughan TL, Whiteman DC (2014) Obesity and risk of esophageal adenocarcinoma and Barrett’s esophagus: a Mendelian randomization study. J Natl Cancer Inst 106(11). doi:10.1093/jnci/dju252
Calle EE, Kaaks R (2004) Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev 4(8):579–591. doi:10.1038/nrc1408
Tilg H, Moschen AR (2006) Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 6(10):772–783. doi:10.1038/nri1937
Garcia JM, Splenser AE, Kramer J, Alsarraj A, Fitzgerald S, Ramsey D, El-Serag HB (2014) Circulating inflammatory cytokines and adipokines are associated with increased risk of Barrett’s esophagus: a case-control study. Clin Gastroenterol Hepatol (The Official Clinical Practice Journal of the American Gastroenterological Association) 12(2):229–238 e223. doi:10.1016/j.cgh.2013.07.038
Rubenstein JH, Kao JY, Madanick RD, Zhang M, Wang M, Spacek MB, Donovan JL, Bright SD, Shaheen NJ (2009) Association of adiponectin multimers with Barrett’s oesophagus. Gut 58(12):1583–1589. doi:10.1136/gut.2008.171553
Thompson OM, Beresford SA, Kirk EA, Bronner MP, Vaughan TL (2010) Serum leptin and adiponectin levels and risk of Barrett’s esophagus and intestinal metaplasia of the gastroesophageal junction. Obesity 18(11):2204–2211. doi:10.1038/oby.2009.508
Doyle SL, Donohoe CL, Finn SP, Howard JM, Lithander FE, Reynolds JV, Pidgeon GP, Lysaght J (2012) IGF-1 and its receptor in esophageal cancer: association with adenocarcinoma and visceral obesity. Am J Gastroenterol 107(2):196–204. doi:10.1038/ajg.2011.417
Donohoe CL, Doyle SL, McGarrigle S, Cathcart MC, Daly E, O’Grady A, Lysaght J, Pidgeon GP, Reynolds JV (2012) Role of the insulin-like growth factor 1 axis and visceral adiposity in oesophageal adenocarcinoma. Br J Surg 99(3):387–396. doi:10.1002/bjs.8658
Greer KB, Thompson CL, Brenner L, Bednarchik B, Dawson D, Willis J, Grady WM, Falk GW, Cooper GS, Li L, Chak A (2012) Association of insulin and insulin-like growth factors with Barrett’s oesophagus. Gut 61(5):665–672. doi:10.1136/gutjnl-2011-300641
WCRF World Cancer Research Fund/American Institute for Cancer Research (2007) Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Washington DC
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Nimptsch, K., Steffen, A., Pischon, T. (2016). Obesity and Oesophageal Cancer. In: Pischon, T., Nimptsch, K. (eds) Obesity and Cancer. Recent Results in Cancer Research, vol 208. Springer, Cham. https://doi.org/10.1007/978-3-319-42542-9_4
Download citation
DOI: https://doi.org/10.1007/978-3-319-42542-9_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-42540-5
Online ISBN: 978-3-319-42542-9
eBook Packages: MedicineMedicine (R0)